Effects of Saireito on the ovarian function of patients with polycystic ovary syndrome
Tóm tắt
It is sometimes difficult to restore a regular ovulatory cycle in women with polycystic ovary syndrome (PCOS) using classic agents such as clomiphene citrate or gonadotropins. Saireito, a herbal medicine, is believed to have an effect similar to corticosteroids. We examined the effect of Saireito on ovulatory induction and endocrine status in women with PCOS. Twenty-four women with PCOS were treated with Saireito for 3 months. Serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin (PRL), testosterone (T), estradiol (E2), adrenocorticotropic hormone (ACTH), and cortisol were measured before and after treatment, and ovulation was assessed. We compared serum LH levels between ovulation (n = 21) and anovulation (n = 3) groups, and compared ovulation rate and serum LH levels between obese (n = 6) and nonobese (n = 18) groups. Ovulation was restored in 21 (87.5%) of the 24 PCOS patients following administration of Saireito for 3 months. LH levels were significantly decreased 1 month after medication in ovulatory group (P < 0.001), but only slightly decreased in anovulatory group. Ovulation rate in the nonobese group (94.4%) was higher than in the obese group (66.7%). Serum LH levels were significantly reduced in the nonobese group, but only slightly reduced in the obese group. Saireito reduced serum LH levels and increased ovulatory rate, particularly in nonobese women.
Tài liệu tham khảo
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
Japan society of Obstetrics and Gynecology, Committee of Reproductive and Endocrinology. Annual report of committee of reproductive and endocrinology, Japan society of obstetrics and gynecology. Nippon Sanka Fujinka Gakkai Zasshi. 2007;59:868–86 (in Japanese).
Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89:505–22.
Fujisawa J, Shimizu S, Matsukawa H, Tomita Y. Efficacy of Sairei-to for treating lymphedema of the arm after surgery for breast cancer. Jpn J Breast Cancer. 2000;15(2):163–6 (in Japanese).
Liu XY. Therapeutic effect of Chai-ling-tang (Sairei-to) on the steroid-dependent nephritic syndrome in children. Am J Chin Med. 1995;23:255–60.
Noma T, Nakajima T, Kawano Y, Yoshizawa I, Kabuki T, Baba M. Inhibitory effect of Kanpo-medicenes: saiboku-to, syouseryu-to, sairei-to on dermatorhacoides farinae antigen-induced IL2 responsiveness in lymphocytes from patients with bronchial asthma and their comparison. Jpn J Allergol. 1996;45:494–532 (in Japanese).
Takahashi K, Kitao M. Effect of TJ-68 (shakuyaku-kanzo-to) on polycystic ovarian disease. Int J Fertil Menopausal Stud. 1994;39:69–76.
Ushiroyama T, Ikeda A, Sakai M, Hosotani T, Suzuki Y, Tsubokura S, Ueki M. Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion. J Reprod Med. 2001;46:451–6.
Takakuwa K, Ishii K, Takaki Y, et al. Effect of Sairei-to combined with aspirin and prednisolone on four recurrent reproductive failure women who are positive for anti-phospholipid antibodies. Am J Chin Med. 2003;31:659–63.
Nakano Y, Suda T, Tozawa F, Dobashi I, Sato Y, Ohmori N, Sumitomo T, Demura H. Saireito (a Chinese herbal drug)-stimulated secretion and synthesis of pituitary ACTH are mediated by hypothalamic corticotrophin-releasing factor. Neurosci Lett. 1993;160:93–5.
Jones GES, Howard JE, Langford H. The use of cortisone in follicular phase disturbance. Fertil Steril. 1953;4:49–62.
Azziz R, Black VY, Knochenhauer ES, Hines GA, Boots LR. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. J Clin Endocrinol Metab. 1999;84:946–50.
Daly DC, Walters CA, Soto-Albors CE, Tohan N, Riddick DH. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril. 1984;41:844–8.
Parsanezhad ME, Alborzi S, Motazedian S, Omrani G. Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: a prospective, double-blind, placebo-controlled trial. Fertil Steril. 2002;78:1001–4.
Sakai A, Kondo Z, Kamei K, Izumi S, et al. Induction of ovulation by Sairei-to for polycystic ovary syndrome patients. Endocr J. 1999;46:217–20.
Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453–5.
Takenaka T, Okitsu-Negishi S, Hashira T, Abe T, Yoshino K. The dichotomy effect of Saireito on the cytokine production from peritoneal macrophages of mice. Ensho (Jpn J Inflamm). 1994;14(4):371–7 (in Japanese).